FIELD NOTES / ARTICLES

PEPTIDE SCIENCE

Testing & Quality

What Does 99% Peptide Purity Actually Mean?

A peptide labeled “99% pure” may sound nearly perfect. But that number answers a narrower analytical question than many people realize. Here’s what peptide purity can tell us—and what it cannot.

The Amino Report Editors

PUBLISHED

UPDATED

8 min read

HPLC chromatogram with a 99.2% main peptide peak and smaller detectable peaks.
HPLC chromatogram with a 99.2% main peptide peak and smaller detectable peaks.

A peptide accompanied by a certificate showing 99.2%, 99.6%, or 99.9% purity can appear to provide a remarkably simple answer to a complicated question.

The number looks definitive.

It isn't.

Purity measurements can provide important information about a peptide sample, but understanding that number requires knowing what was measured, how it was measured, and what the analytical method was capable of detecting.

A result such as “99% purity” should therefore be understood as one piece of an analytical picture—not a universal measure of quality.


Start with what HPLC actually does

High-performance liquid chromatography, or HPLC, is one of the most commonly used techniques for evaluating peptide purity.

In simplified terms, HPLC separates components of a sample as they travel through a chromatographic column. Different compounds can move through the system at different rates, producing peaks on a chromatogram.

The primary peptide may produce one large peak, while detectable impurities may appear as smaller peaks elsewhere in the chromatogram.

When a laboratory reports a value such as 99.4% purity, that percentage is commonly based on the relative area of the primary chromatographic peak compared with the other detected peaks under the conditions of that particular method.

That is useful information—but notice what it does not necessarily say. It does not automatically prove the molecular identity of the main peak, establish the exact amount of peptide present in the vial, or detect every possible contaminant that could be present.


Purity is not the same thing as identity

One of the most important distinctions in peptide analysis is the difference between purity and identity.

Chromatographic purity asks, essentially, how much of the detected chromatographic signal is associated with the primary peak relative to other detected peaks.

Identity asks a different question: Is the material represented by that peak actually the compound it is claimed to be?

This is where techniques such as mass spectrometry become important. Mass spectrometry can provide information about molecular mass and help determine whether the material is consistent with the expected peptide.

Put simply, HPLC can provide strong evidence about how chromatographically clean a sample appears, while mass spectrometry can provide evidence about what the material actually is.

Neither number should automatically be treated as a substitute for the other.


Purity is not the same thing as peptide content

There is another distinction that is particularly easy to miss: purity does not necessarily tell you how much peptide is actually present in a vial.

Imagine a sample containing one dominant peptide component and relatively few detectable peptide-related impurities. That sample could produce a very high chromatographic purity result.

But the purity percentage alone does not establish that a vial labeled as containing a particular quantity actually contains that quantity of peptide.

Determining peptide content or quantity requires an analytical approach designed to answer that question. This is why a certificate displaying an impressive purity percentage should not automatically be interpreted as confirmation of labeled peptide content.


Why one analytical method rarely tells the whole story

Peptides can present analytical challenges because impurities may be chemically similar to the target compound. During synthesis, related substances can arise from incomplete reactions, sequence variations, degradation, oxidation, or other chemical changes.

Some of these compounds may behave similarly during chromatography, which is one reason analytical methods are evaluated for factors such as resolution, selectivity, sensitivity, and specificity.

This is also why complementary techniques matter. HPLC, mass spectrometry, peptide content assays, and other analytical methods can answer different questions about the same sample.

The strongest analytical picture is therefore usually not a single impressive number. It is a collection of results that support one another.


What should you look for on a peptide COA?

A Certificate of Analysis can contain useful information, but the presence of a COA alone does not tell you how thoroughly a sample was characterized.

When reviewing analytical documentation, useful questions include: What method was used? Is the sample or batch clearly identified? Is the reported result supported by actual analytical data? Was identity tested separately from purity? And does the documentation show who performed the analysis and when it was performed?

A chromatogram can provide considerably more context than a purity number by itself. Likewise, mass-spectrometry data can provide information that a chromatogram alone cannot.

The goal is not simply to find the highest percentage printed on a document. It is to understand what evidence actually supports the characterization of the sample.


Is 99.9% meaningfully better than 99%?

At first glance, the difference between 99.0% and 99.9% purity can look substantial. One number simply appears better.

Analytically, however, those percentages should not be compared in isolation.

A 99.9% result obtained using one chromatographic method is not automatically stronger evidence of sample quality than a 99.0% result obtained using another. Differences in column chemistry, separation conditions, detection methods, integration parameters, and the ability of the method to resolve closely related impurities can all affect the result.

More importantly, the extra decimal place does not answer the other analytical questions discussed above. A 99.9% HPLC result still does not, by itself, establish identity, peptide content, or the absence of substances the method was not designed to detect.

The more useful question is therefore not simply “How high is the purity percentage?”

It is “How was that number established, and what other evidence supports it?”


A better way to read the number

A peptide purity percentage is useful—but only when interpreted in context.

Instead of treating “99% pure” as a universal quality score, it is more accurate to view it as the result of a particular analytical measurement performed under defined conditions.

Good analytical characterization asks several separate questions: Does the sample contain the expected compound? How well is it separated from detectable related impurities? How much peptide is actually present? And what are the limitations of the methods used to answer those questions?

No single percentage answers all of them.

That is why the analytical documentation behind the number can ultimately be more informative than the number itself.

SOURCES / REFERENCES

Key sources include peer-reviewed literature on peptide chromatography, mass spectrometry, analytical characterization, and reference standards.

  1. Mant CT, Chen Y, Yan Z, Popa TV, Kovacs JM, Mills JB, Tripet BP, Hodges RS. HPLC analysis and purification of peptides. Methods in Molecular Biology. 2007. DOI: 10.1007/978-1-59745-430-8_1.

  2. Prabhala BK, Mirza O, Højrup P, Hansen PR. Characterization of Synthetic Peptides by Mass Spectrometry. Methods in Molecular Biology. 2015;1348:77–82. DOI: 10.1007/978-1-4939-2999-3_9.

  3. Li M, Josephs RD, Daireaux A, et al. Identification and accurate quantification of structurally related peptide impurities in synthetic human C-peptide by liquid chromatography-high resolution mass spectrometry. Analytical and Bioanalytical Chemistry. 2018;410:5059–5070. DOI: 10.1007/s00216-018-1155-y.

  4. Lian Z, Wang N, Tian Y, Huang L. Characterization of Synthetic Peptide Therapeutics Using Liquid Chromatography-Mass Spectrometry: Challenges, Solutions, Pitfalls, and Future Perspectives. Journal of the American Society for Mass Spectrometry. 2021;32(8):1852–1860. DOI: 10.1021/jasms.0c00479.

  5. Wang C, et al. Reference Standards to Support Quality of Synthetic Peptide Therapeutics. AAPS Journal. 2023.


CONTINUE READING

Related Articles

Testing & Quality

A peptide labeled “99% pure” may sound nearly perfect. But that number answers a narrower analytical question than many people realize. Here’s what peptide purity can tell us—and what it cannot.

Testing & Quality

A Certificate of Analysis can look authoritative at a glance. But what information actually makes a COA useful—and what can a single document really establish about a peptide sample?

Compound Research

Retatrutide is an investigational triple receptor agonist targeting GIP, GLP-1, and glucagon receptors. This review examines its mechanism, published clinical research, emerging Phase 3 findings, and the questions that remain unanswered.

THE AMINO REPORT

Peptide science, research, and analysis.